Report of the meeting on Aspartame with National Experts
2010; European Food Safety Authority; Volume: 7; Issue: 5 Linguagem: Inglês
10.2903/sp.efsa.2010.zn-002
ISSN2397-8325
Tópico(s)Sensory Analysis and Statistical Methods
ResumoEFSA Supporting PublicationsVolume 7, Issue 5 1641 Technical reportOpen Access Report of the meeting on Aspartame with National Experts European Food Safety Authority (EFSA), European Food Safety Authority (EFSA)Search for more papers by this author European Food Safety Authority (EFSA), European Food Safety Authority (EFSA)Search for more papers by this author First published: 19 May 2010 https://doi.org/10.2903/sp.efsa.2010.ZN-002Citations: 1 Published date: 19 May 2010 Question number: EFSA-Q-2009-00488 AboutPDF ToolsExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References Anon, 2002. Editorial. Case reports, case series and systematic reviews. Q J Med, 95, 197– 198. Appleton KM, Rogers PJ, Blundell JE, 2004. Effects of a sweet and non-sweet lunch on short term appetite: differences in female high and low consumers of sweet/low-energy beverages. J Hum Nut Diet. 17, 425– 434 Appleton KM and Blundell JE, 2007 Habitual high and low consumers of artificially-sweetened beverages: Effects of sweet taste and energy on short-term appetite. Physiol. & Behav. 92, 479– 486 Arcella D, Le Donne C, Piccinelli R, Leclerq C 2004. Dietary estimated intake of intense sweeteners by Italian teenagers. Pt levels and projections derived from the INRAN-RM-2001 food survey. Food and Chemical Toxicology 42, 677– 685 Bandyopadhyay A, Ghoshal S, Mukherjee A, 2008. Genotoxicity Testing of Low-Calorie Sweeteners: Aspartame, Acesulfame-K and Saccharine. Drug and Chemical Toxicology 31, 447– 457 Bech B, Burlet A, Max JP, Srticker-Krongrad A, 2002. Effects of long-term ingestion of aspartame on hypothalamic neuropeptide Y, plasma leptin and body weight gain and composition. Pysiol & Behav., 75, 41– 47 Belpoggi F, Soffritti M, Padovani M, Degli Esposti D, Lauriola M, Minardi F. 2006. Results of long-term carcinogenicity bioassay on Sprague-Dawley rats exposed to aspartame administered in feed. Ann N Y Acad Sci. 1076, 559– 77. Bergen D, Yeh MC, 2006. Effects of energy-content labels and motivational posters on sales of sugar-sweetened beverages: Stimulating sales of diet drinks among adults study. J Am Dietetic Assoc. 106 1866– 1869 Blumenthal HJ, Vance DA, 1997. Chewing gum headaches. Headache 37, 665– 666 Bradstock MK, Serdula MK, Marks JS, Barnard RJ, Crane NT, Remington PL, Towbridge FL, 1986. Evaluation of reactions to food additives: the aspartame experience. Am J Clin Nut, 3 464– 469 Bunin GR, Kushi LH, Gallagher PR, Porke-Adams LB, McBride ML, Ccaan A, 2005. Maternal diet during pregnancy and its association with medulloblastoma in children: A children's oncology group study (United States). Cancer Causes and Control 16, 877– 891 Butchko HH, Stargel WW, Comer CP, Mayhew DA, Benninger C, Blackburn GL, de Sonneville LMJ, Geha RS, Hertelendy Z, Koester A, Leon AS, Liepa GU, McMartin KE, Mendenhall CL, Munro IC, Novotny EJ, Renwick G, Schiffman SS, Schomer DL, Shaywitz BA, Spiers PA, Tephly TR, Thomas JA, Trefz FK, 2002. Aspartame: Review of Safety. Reg Toxicol Pharmacol 35, S1– S93 Camfield PR, Camfield CS, Dooley JM, Gordon K, Jollymore S, Weaver DF, 1992. Aspartame exacerbates EEG spike-wave discharge in children with generalzed absence epilepsy: a double-blind controlled study. Neurology, 42, 1000– 1003 Canimoglu S, Rencuzogullari E, 2006. The cytogenetic effects of food sweetener maltitol in human peripheral lymphocytes, Drug Chem Toxicol, 29(3), 269– 278 Christian B, McConnaughey K, Bethea E, Brantley S, Coffey A, Hammond L, Harrel S, Metcalf K, Muehlenbein D, Spruill W, Brinson L, McConnaughey M, 2004. Chronic aspartame affects T-maze performance, brain cholinergic receptors and Na+,K+-ATPase in rats. Pharmacology, Biochemistry and Behaviour 78, 121– 127 Chung MS, Suh HJ, Yoo W, Choi SH, Cho YJ, Cho YH, Kim CJ, 2005. Daily intake assessment of saccharin, stevioside, D-sorbitol and aspartame from various processed foods in Korea. Food Additives and Contaminants 22 (11), 1087– 1097 Drake ME, 1986. Panic attacks and excessive aspartame ingestion. Lancet, 13, 631 Dutheil F, Beaune P, Loriot MA, 2007. Xenobiotic metabolising enzymes in the central nervous system: Contribution of cytochrome P450 enzymes in normal and pathologic human brain. Biochimie 90, 426– 436 Elfhag K, Tynelius P, Rasmussen F, 2007. Sugar-sweetened and artificially sweetened soft drinks in association to restrained, external and emotional eating. Physiol. & Behav. 91, 191– 195 Eshel Y, Sarova-Pinhas I, 1993. Aspartame and seizures. Neurology, 43, 2154– 2155 European Commission Report on Dietary Food Additive Intake in the European Union 2004. http://europa.eu.int/comm/food/fs/sfp/addit_flavor/flav15_en.pdf EFSA, 2006. Opinion of the scientific panel on food additives, flavourings, processing aids and materials in contact with food (AFC) on a request from the Commission related to a new long-term carcinogenicity study on aspartame. Question number EFSA-Q-2005-122. The EFSA Journal, 356 1– 44 EFSA, 2009. Updated Scientific Opinion of the Panel on Food Additives and Nutrient Sources added to Food on a request from the European Commission related to the 2nd ERF carcinogenicity study on aspartame taking into consideration study data submitted by the Ramazzini Foundation in February 2009. The EFSA Journal 1015, 1– 18 Ferland A, Brassard P, Poirier P 2007. Is aspartame really safer in reducing the risk of hypoglycaemia during exercise in patients with type 2 diabetes? Diabetes care 30(7), e59 Fernstrom JD, 2009. Aspartame effects on the brain. European Journal of Clinical Nutrition 63, 698– 9 Flood JE, Roe LS, Rolls BJ, 2006. Effect of increased beverage portion size on energy intake at a meal. J Am Diet Assoc. 106, 1984– 1990 FDA (Food and Drug Administration), 2010. Summary of the adverse rections attributed to Aspartame 1994–1998. Internal memoranda. Food Standards Agency UK, 2003. Diary survey of the intake of intense sweeteners by young children from soft drinks. No. 36/03 Food Standards Australia New Zealand, 2004. Consumption of intense sweeteners in Australia and New Zealand: Benchmark Survey 2003. Evaluation Report series no 8 Fujita T, Nakamura K, Yamazaki A, Ozaki M, Sahashi K, Shichio K, Nomura K, Maeda M, Nakamura T, Yokota S, Kuroyama S, Kumagai Y, Majima M, Ohtani Y, 2007. Effects of L-phenylalanine supplementation and a high protein diet on pharmacokinetics of cefdinir in healthy volunteers: an exploratory study. J Clin Parmacy Therapeutics 32, 277– 285 Gallus S, Scotti L, Negri E, Talami R, Franceschi S, Montella M, Giacosa A, Dal Maso L, La Vecchia L, 2007. Artificial sweeteners and cancer risk in a network of case-control studies. Annals of Oncology 18, 40– 4 Garriga MM, Berkebile C and Metcalfe DD, 1991. A combined single-lind, double blind, placebo-controlled study to determine the reporducibility of hypersensitivy reactions to aspartame. J Allergy Clin. Immunol. 87, 821– 7 Geha RS, Buckley CE, Greenberger P, Patterson R, Polmar S, Saxon A, Rohr A, Yang W, and Drouin M, 1993. Aspartame is no more likely than placebo to cause urticaria/angiodema: Results of a multicenter, randomized, double-blind, placebo-controlled, crossover study. J. Allergy Clin. Immunol. 92, 513– 520 Geha RS, 1992. Aspartame-induced lobular panniculitis. J Am Acad Dermatol, 26, 277– 278 Gerrard JW, Richardson JS, Donat J, 1994. Neuropharmacological evaluation of movement disorder that are adverse reactions to specific foods. In J Neurosci, 76, 61– 69 Glasziou P, Vandenbroucke J, Chalmers I. 2004. Assessing the quality of research. BMJ. 328: 39– 41 González-Quevedo A, Obergón F, Urbina M, Roussó T, Lima L. 2002. Effect of chronic methanol administration on amino acids and monoamines in retina, optic nerve, and brain of rat. Toxicology and Applied Pharmacology 185, 77– 84 Gulya AJ, Sessions RB, Troost TR, 1992. Aspartame and dizziness: preliminary results of prospective, non-blinded, prevalence and attempted cross-over study. Am J Otol, 13, 438– 442 Hardell L, Mild KH, Pahlson A Hallquist A, 2001. Ionizing radiation, cellular telephones and the risk of brain tumours. European Journal of Cancer Prevention 10, 523– 529 Hennekens CH, Buring JE, Mayrent SL. 1987. Epidemiology in Medicine. Little Brown and Co. Boston/Toronto. 1st edition. Hetherington MM and Boyland E, 2007. Short-term effects of chewing gum on snack intake and appetite. Appetite. 48 397– 401 Hill AM, Belsito DV, 2003. Systemic contact dermatitis of the eyelids caused by formaldehyde derived from aspartame? Contact Dermatitis, 49, 258– 259 Humphries P, Pretorius E, Naudé H, 2008. Direct and indirect cellular effects of aspartame on the brain. European Journal of Clinical Nutrition 62, 451– 462 Illback NG, Alzin M, Jahrl S, Enghardt-Barbieri H, Busk L 2003. Estimated intake of the artificial sweeteners acesulfame-K, aspartame, cyclamate and saccharin in a group of Swedish diabetics. Food Additives and Contaminants 20, 99– 114 Institute of Medicine, 2005. Protein and amino acids in dietary reference intakes for energy, carbohidrate, fiber, fat, fatty acids, cholesterol protein ans amino acids. National Academies Press, Washington DC 701– 728. Jacob SE, Stechschulte S, 2008. Formaldehyde, aspartame and migraines: A possible connection. Dermatitis, 19, 10– 11 Johns DR, 1986. Migraie provoked by aspartame. N Engl J Med, 315, 456 Julis RA, Mattes RD, 2007 Influence of sweetened chewing gum on appetite, meal patterning and energy intake. Appetite 48, 167– 175 Just T, Pau HW, Engel U, Hummel T, 2008. Cephalic phase insulin release in healthy humans after taste stimulation? Appetite 51, 622– 627 Klein DA, Boudreu GS, Devlin MJ, Walsh BT, 2006. Artificial sweetener use among individuals with eating disorders. Int J Eat Disord. 39, 341– 345 Kulczycki A Jr, 1986. Aspartame-induced urticaria. Ann. Intern. Med. 104, 207– 208 Lau K, MeLean WG, Williams DP, Howard CV, 2006. Synergistic interactions between commonly used food additives in a developmental neurotoxicity test Toxicological Sciences 90, 178– 187 Leclercq C, Arcella D, Amentia A, Boon PE, Kruizinga AG, Gilsenan MB, Thompson RL, 2003. Development of databases for use in validation studies of probabilistic models of dietary exposure to food chemicals and nutrients. Food additivies and Contaminats 20(S1) S27– S35 Leth T, Fabricius N, Fagt S, 2007. Estimated intake of intense sweeteners from non-alcoholic beverages in Denmark. Food Additives and Contaminants 24(3), 227– 235 Lindon JC, Nicholson JK, Holmes E, et al. 2005. Summary recommendations for standardization and reporting of metabolomic analyses. Nat. Biotechnol. 23, 833– 838. Lim U, Subar AF, Mouw T, Hartge P, Morton LM, Stolzenberg-Solomon, Sampbell D, Hollenbeck AR, Schatzkin A, 2006. Consumption of aspartame-containing beverages and incidence of hematopoietic and brain malignancies. Cancer Epidemiology Biomarkers & Prevention 15, 1654– 1659 Lino, CM, Costa IM, Pena A, Ferreira R, Cardoso SM, 2008. Estimated intake of the sweeteners, acesulfame-K and aspartame, from soft drinks, soft drinks based on mineral waters and nectars for a group of Portuguese teenage students. Food Addit Contam 20, 1– 6 Magnuson BA, Burdock GA, Doull J, Kroes RM, Marsh GM, Panza W, Spencer PS, Wadell WJ, Wlker R, Williams GM, 2007. Aspartame: A safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies. Critical Reviews in Toxicology 37(8), 629– 727 Matsumoto K, Moriya F, and Nanikawa R, 1990. The movement of blood formaldehyde and its metabolism in the rabbit. Nippon Hoigaiku Zasshi. 44, 205– 211 McCauliffe DP, and Poitras K, 1991. Aspartame-induced lobular panniculitis. J. Am. Acad. Dermatol. 25, 298– 300 Meyer RP, Gehlhaus M, Knoth R, Volk B, 2007. Expression and function of cytochrome p450 in brain drug metabolism. Curr Drug Metab 8, 297– 306 Mortelmans LJ, Van Loo M, De Cauwer HG, Merlevede K. 2008. Seizures and Hyponatremia after excessive intake of diet coke. Eur. J. Emerg. Med. 15, 51 Miksys S, Tyndale RF. 2008 Brain drug-metabolizing cytochrome P450 enzymes are active in vivo, demonstrated by mechanism-based enzyme inhibition. Neuropsychopharmacology 34, 634– 640 Mobini S, Chambers LC, Yeomans MR, 2007. Effects of hunger state on flavour pleasantness conditioning at home: Flavour-nutrient learning vs. flavour-flavour learning. Appetite 48, 20– 28 Nakao H, Umebayashi C, Nakata M, Nishizaki Y, Noda K, Okano Y, Oyama Y, 2003. Formaldehyde-induced shrinkage of rat thymocytes. J Pharmacol Sci 91, 83– 86 National Toxicology Program NTP Report on toxicity studies of acesulfame potassium (CAS N0. 55589-62-3) in FVB/N-TgN(v-Ha-ras)Led (Tg.AC) hemizygous mice and carcinogenicity studies of acesulfame potassium in B6.129-Trp53tm1Brd (N5) haploinsufficient mice, 2005. NIH Publication No. 06-4459,1-224. National Toxicology Program NTP-CERHR, 2003. Monograph on the potential human reproductive and developmental effects of methanol. NIH Publication No. 03-4478 Newman LC, Lipton RB, 2001. Migraine MLT-down: n unusual presentation of migraine in patients with aspartame-triggered headaches. Headache 41, 899– 901 Norwegian Scientific Committee for Food Safety, 2007 Impact on health when sugar is replaced with intense sweeteners in soft drinks, ‘saft’ and nectar. Report 1 Novick NL 1985. Aspartame-induced granulomatous panniculitis. Ann. Intern. Med. 102, 206– 207 Oyama Y, Sakai H, Arata T, Okano Y, Akaike N, Sakai K, Noda K, 2002. Cytotoxic effects of methanol, formaldehyde and formate on dissociated rat thermocytes : A possibility of aspartame toxicity. Cell Biol Toxicol. 18, 43– 50 Parthasarathy NJ, Kumar RS, Manikandan S, Narayanan GS, Kumar RV, Devi RS, 2006. Effect of methanol-induced oxidative stress on the neuroimmune system of experimental rats. Chem Biol Interactions 161, 14– 25 Parthasarathy, NJ, Srikumar R, Manikandan S, Narayanan GS, Devi RS, 2007. Effect of methanol intoxication on specific immune functions of albino rats. Cell Biology and Tox, 23, 117– 187 Reed BE, Barrett AP, Katelaris C, Bilous M, 1993. Orofacial sensitivity reactions and the role of dietary components. Case reports. Aust Dent J, 38, 287– 291 Reid M, Hammersley R, Hill AJ, Skidmore P, 2007. Long-term dietary compensation for added sugar: effects of supplementary sucrose drinks over a 4-week period. Br J Nut 97, 193– 203 Rencuzogullari E, Tűylű BA, Topaktas M, Ila HB, Kayraldrz A, Arslan M, Diler SB, 2004. Genotoxicity of spartame, Drug Chem Toxicol, 27(3), 257– 268 Renwick AG, 2006. The intake of sweeteners - an update review. Food Additives and Contaminants 23(4), 327– 338 Renwick AG, Nordmann H, 2007. First European conference on aspartame: Putting safety and benefits into perspective. Synopsis of presentations and conclusions. Food and Chemical Toxicology 45, 1308– 1313 Robbins PI, Raymond L, 1999. Aspartame and symptoms of carpal tunnel syndrome. J Occup Environ Med 41, 418 Roberts, HJ, 1988. Reactions attributed to aspartame-containing products: 551 cases. J Appl Nutrition, 40, 85– 94 Roberts, HJ, 2001. Aspartame disease – an ignored epidemic. Sunshine Sentinel Press. SCF (Scientific Committee on Food), 2002. Opinion of the Scientific Committee on Food: Update on the safety of aspartame. European Commission, 10 December 2002 Sargeant JM, Del Rocio Amezcua M, Rajic A, Waddell L. 2005. A Guide to Conducting Systematic Reviews in Agri-Food Public Health. Public Health Agency of Canada, Guelph, Ontario, Canada. Sharma S, Jain NK, Kulkarni SK, 2005. Possible analgesic and anti-inflammatory interactions of aspartame with opioids and NSAIDs. Indian Journal of Experimental Biology 43, 498– 502 Simintzi KH, Schulpis P, Angelogianni C, Liapi S, Tsakiris S, 2008. L-Cysteine and glutathione restore the modulation of rat frontal cortex Na+, K+-ATPase activity induced by aspartame metabolites. Food and Chemical Toxicology 46 2074– 2079 Simintzi I, Schlupis KH, Angelogianni P, Liapi C, Tsakiris S, 2007 The effect of aspartame metabolites on the suckling rat frontal cortex acetylcholinesterase. An in vitro study. Food Chem Toxicol 45, 2397– 2401 (a) Simintzi I, Schulpis KH, Angelogianni P, Liapi C, Tsakiris S, 2007 The effect of aspartame on acetylcholinesterase activity in hippocampal homogenates of suckling rats. Pharmacological Research 56, 155– 159 (b) Smith JD, Terpening CM, Schmidt SO, Gums JG, 2001. Relief of fibromyalgia symptoms following discontinuation of dietary excitotoxins. Ann Pharmacother. 35, 702– 706 Soffritti M, Belpoggi F, Espositi DD, Lambertini L, 2005. Aspartame induces lymphomas and leukaemias in rats. Eur J Oncol. 10, 107– 116 Soffritti M, Belpoggi F, Espositi DD, Lambertini L, Tibaldi E, Rigano A, 2006. First experimental demonstration of the multipotential carcinogenic effects of aspartame administered in the feed to sprague-dawley rats. Env Health Pers. 114, 379– 385 Soffritti M, Belpoggi F, Tibaldi E, Esposti DD, Lauriola M, 2007. Life-span exposure to low doses of aspartame beginning during prenatal life increases cancer effects in rats. Envrion. Health Perspect 115, 1293– 1297 Soffritti M, Belpoggi F, Esposti DD, Falcioni L, Bua L, 2008. Consequences of exposure to carcinogens beginning during developmental life. Basic & Clin. Pharmacol & Toxicol 102, 118– 124 Stegink, LD, Brummel MC, McMartin K, Martin-Amat G, Filer LJ Jr, Baker GL, and Tephly, TR, 1981. Blood methanol concentrations in in normal adult subjects administered abuse doses of aspartame. J Toxicol Environ Health. 7, 281– 290 Szucs EF, Barrett KE, and Metcalfe DD, 1986. The effects of aspartame on mast cells and basophils. Food Chem. Toxicol. 24, 171– 174 Tollefson L, Barnard RJ, 1992. An analysis of FDA passive surveillance reports of seizures associated with consumption of aspartame. J Am Diet Assoc, 92, 598– 601 Tsakiris S, Giannoulia-Karantana A, Simintzé I, Schulpis KH, 2006. The effect of aspartame metabolites on human erythrocyte membrane acetylcholinesterase activity. Pharmacological Research 53, 1– 5 Tutelyan VA, Kravchenko LV, Kuzmina EE, 1990. The effect of aspartame on the activity of rat liver xenobiotic-metabolizing enzymes. Drug metabolism and Disposition: The Biological Fate of Chemicals 18, 223– 225 van Rooij-van den Bos, Konings EJM, Heida P, van Hamersveld ICM, van der Wielen J, Kooijman M, 2004. Onderzoek naar de kunstmatige zoetstoffen Sacharine, Aspartaam, Acesulfaam-K en Cyclamaat in levensmiddelen. Dutch Food and Consumer Product Safety Authority 2004 (report in Dutch) http://www2.vwa.nl/CDL/files/15/1004/10450%20200412_zoetstoffen.pdf van Wymelbeke V, Béridot-Thérond M-E, de La Guéronnière V, Fantino M, 2004. Influence of repeated consumption of beverages containing sucrose or intense sweeteners on food intake. Eu J Clin Nut. 58, 154– 161 Vandenbroucke J. 2001. In defence of case reports and case series. Ann. Intern Med., 134: 330– 334. Vences-Meja A, Labra-Ruiz N, Hernandez-Martinez N, Dorado-Gonzalez V, Gomez-Garduno J, Perez-Lopez I, Nosti-Palacios R, Carranza RC, Espinosa-Aguirre JJ, 2006. The effect of aspartame on rat brain xenobiotic-metabolizing enzymes. Hum Exp Toxicol. 25, 453– 459 Walton RG, 1986. Seizure and mania after high intake of aspartame. Psychosomatics, 27, 218– 220 Weihrauch MR, Diehl V, 2004. Artificial sweeteners–do they bear a carcinogenic risk? Annals of Oncology 15, 1460– 1465 Wurtman RJ, 1985. Aspartame: possible effect on seizure susceptibility. Lancet, 2, 1960 Citing Literature Volume7, Issue5May 20101641 ReferencesRelatedInformation
Referência(s)